MLchartDataset catalogue

Votrient

Term · Oncology and biomedicine · MLC-T-ONC-009321

A drug used to treat adults with advanced renal cell carcinoma (a type of kidney cancer) or advanced soft tissue sarcoma that has already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Votrient blocks certain proteins, which may prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called GW786034 and pazopanib hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-009321
FieldOncology and biomedicine
SynonymsGW786034; pazopanib hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009321",
  "term": "Votrient",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with advanced renal cell carcinoma (a type of kidney cancer) or advanced soft tissue sarcoma that has already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Votrient blocks certain proteins, which may prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called GW786034 and pazopanib hydrochloride.",
  "synonyms": [
    "GW786034",
    "pazopanib hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/votrient/"
}

Record 17,352 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.